Case Study: QC Systems to Comply with CAP, CLIA, and Regulatory Guidelines Webinar

Catalyzing Implementation of NGS-Based Tests - Part 2 of 4

ODWSD: Development & Validation Cancer Hotspot

This webinar is the second in a four-part series highlighting real-world examples of how some lab directors are bringing validated next-generation sequencing-based tests to the clinic. In this case study, Gregory J. Tsongalis of Dartmouth Hitchcock Medical Center will discuss how his lab developed and validated a cancer hotspot assay.

View now to learn more about:

  • How new test methodolgies are compared to results from established validated procedures
  • Sample preparation, sequencing, and data analysis
  • Validation goals and trending metrics

You can find the other parts of the series below:

Fill out the form and watch today!

Complete this form for your free download:

We’re committed to your privacy. SeraCare will not share or sell your data. View our privacy policy below for details.